Hana Pharm Co Ltd (293480) — Capital Reinvestment Ratio
Hana Pharm Co Ltd (293480) has a Capital Reinvestment Ratio of 42.57x as of June 2025, meaning it reinvests 43% of its operating cash flow (₩235.15 Million) in capital expenditures (₩10.01 Billion). See Hana Pharm Co Ltd net asset quality index to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Hana Pharm Co Ltd Capital Reinvestment Ratio (2016–2024)
This chart tracks Hana Pharm Co Ltd's Capital Reinvestment Ratio across 9 annual periods. Check Hana Pharm Co Ltd investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Hana Pharm Co Ltd (2016–2024)
Year-by-year Capital Reinvestment Ratio for Hana Pharm Co Ltd from 2016 to 2024. For live market cap and broader valuation context, see market cap of Hana Pharm Co Ltd.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.52x | ₩25.30 Billion | ₩13.21 Billion | ▼ -34.6% |
| 2023 | 0.80x | ₩18.40 Billion | ₩14.68 Billion | ▼ -31.1% |
| 2022 | 1.16x | ₩30.88 Billion | ₩35.77 Billion | ▼ -14.6% |
| 2021 | 1.36x | ₩25.66 Billion | ₩34.81 Billion | ▲ +23.3% |
| 2020 | 1.10x | ₩15.58 Billion | ₩17.14 Billion | ▲ +3.4% |
| 2019 | 1.06x | ₩31.72 Billion | ₩33.73 Billion | ▲ +426.7% |
| 2018 | 0.20x | ₩27.59 Billion | ₩5.57 Billion | ▼ -49.7% |
| 2017 | 0.40x | ₩25.38 Billion | ₩10.19 Billion | ▼ -39.8% |
| 2016 | 0.67x | ₩12.46 Billion | ₩8.31 Billion | — |